American Academy of Microbiology, 2022Four microbiology experts from the Chinese mainland were selected

2022-05-13 0 By

Four microbiology experts from mainland China have been selected as members of the American Academy of Microbiology in 2022: Yuelong Shu, Ph.D., School of Public Health (Shenzhen), Sun Yat-sen University;Shu Yuelong is currently the deputy Director of National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, director of national Influenza Center, member of asia-pacific Influenza Commission and expert group on Influenza Prevention and Control, Ministry of Health.Since April 2017, he has been dean of school of Public Health, Sun Yat-sen University (Shenzhen).On April 23, 2021, he was selected into the effective list of academician co-selection of Chinese Academy of Engineering in 2021.The following awards: 1. Research, Development and utilization of genetic elements in the Herpesvirus Family, First Prize of Scientific and Technological Progress, Ministry of Health, 1998;2. Preparation and application of novel virus vectors, Second Prize of National Science and Technology Progress, 1999;3. Establishment and application of laboratory surveillance technology for human avian influenza, Second Prize of Science and Technology of Chinese Preventive Medical Association, 2007;4. Clinical and Applied Basic Research of Influenza A (H1N1), First Prize of Beijing Science and Technology Award, 2011;5. Research on the etiology of INFLUENZA A (H1N1) and its application in the prevention and control of influenza pandemic, First Prize of Science and Technology of Chinese Preventive Medical Association, 2011;6. Application of pseudo-virus technology platform in influenza and hepatitis C virus research and drug/immune evaluation, Third Prize of Science and Technology of Chinese Preventive Medical Association, 2011;7. Innovative Research on effective Prevention and control and Integration of Influenza A (H1N1) pandemic in China, First Prize of National Science and Technology Progress, 2014;8. Identification of novel avian influenza A (H7N9) virus in humans and its etiology, First Prize of Chinese Medical Science and Technology, 2015;9. Identification of a novel avian influenza A (H7N9) virus and its etiology, First Prize of Science and Technology Award of Chinese Preventive Medicine Association, 2015.Microbiology (Microbiology) Li Huang, Ph.D., Institutes of Microbiology, Chinese Academy of Sciences (CAS);Academic Leader of Innovation Group of The National Natural Science Foundation of China in 2006 (2008-(2007-) Editorial Board of Chinese Journal of Biochemistry and Molecular Biology (2004-)Genetic mechanism of hyperthermophilic archaea Hongzhou Lu, M.D., ph. D., Shanghai Public Health Clinical Center, Fudan University;Hongzhou Lu, Chief physician, second-level professor, adjunct professor, School of Life Sciences, Fudan University, Doctor of Internal Medicine, postdoctoral fellow in THE United States, doctoral supervisor of internal medicine, doctoral supervisor of nursing, master of post-doctoral station, master of public health.He has been selected into the National Project of Millions of Talents, Yangtze River Scholars, enjoys the Special allowance of The State Council, and is “middle-aged and young experts with outstanding contributions”.The Shanghai public health clinical center (fudan university) secretary of the party committee, fudan university, huashan hospital dean assistant, tropical diseases and parasites neurology, former director of committee member of Chinese medical association and the AIDS group leader, Chinese preventive medical association medical institutions of public health management of the branch committee, deputy director of the research direction:The diagnosis, treatment and pathogenesis of infectious diseases Guoping Zhao, Ph., Institute of Plant Physiology and Ecology,Guoping Zhao, Molecular microbiologist, Academician of the Chinese Academy of Sciences, Academician of the Academy of Sciences for Developing Countries, Professor of The Faculty of Medicine of the Chinese University of Hong Kong,Professor, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; Chief scientist, Biomedical Big Data Center, Shanghai Institutes for Biological Sciences; Chief scientist, Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences.In his early years, Zhao was engaged in the research of microbial physiology and biochemistry, metabolic regulation and enzyme action mechanism.Since 1998, he has led the establishment of a genomics research platform and system, participated in human disease genome research, and cloned several pathogenic genes of human genetic diseases.Start the research work of biochip, bioinformatics and proteomics;Participated in establishing human HapMap research technology platform.He initiated the sequencing of microbial genomes in China and led the research on the genomes, functional genomes, comparative and evolutionary genomes of several important microorganisms.Zhao guo-ping actively explored the field of systematic synthetic biology, and made pioneering work on the regulation of microbial metabolism, including the post-translational acetylation modification of metabolic enzymes.Zhao guoping led the cas human Genome research project in 1998.From 2001 to 2003, he completed the cloning of the pathogenic gene of deciduous teeth and the whole genome sequencing of leptospirosis question mark.From 2003 to 2005, he revealed the evolution mechanism of SARS coronavirus.In 2010, he revealed that the metabolic enzyme “acetylation group” is a universal global regulatory mechanism in organisms.In 2018, he developed a batch of cell factories and built the first “single-chromosome beer yeast”.